Drug Shortage Report for APO-QUINAPRIL/HCTZ

Last updated on 2018-04-18 History
Report ID 31022
Drug Identification Number 02408767
Brand name APO-QUINAPRIL/HCTZ
Common or Proper name QUINAPRIL - HCTZ
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) HYDROCHLOROTHIAZIDE QUINAPRIL
Strength(s) 12.5MG 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 30 BLS
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-12-15
Actual start date 2017-12-11
Estimated end date 2018-05-31
Actual end date 2018-04-17
Shortage status Resolved
Updated date 2018-04-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2018-04-18 English Compare
v14 2018-04-17 French Compare
v13 2018-04-17 English Compare
v12 2018-03-20 French Compare
v11 2018-03-20 English Compare
v10 2018-02-26 French Compare
v9 2018-02-26 English Compare
v8 2018-01-16 French Compare
v7 2018-01-16 English Compare
v6 2018-01-03 French Compare
v5 2018-01-03 English Compare
v4 2017-12-14 French Compare
v3 2017-12-14 English Compare
v2 2017-11-28 French Compare
v1 2017-11-28 English Compare

Showing 1 to 15 of 15